“…3,7 Regular follow-up and reintervention are required to maintain patency and long-term clinical success. 3,7 SVC stenting was first described in 1986 2,6,7 and is now a well-established treatment in benign cases of SVCS [2][3][4][5]8,11 related to MF. 8,10 The advantages of stenting include the rapid relief of symptoms, low morbidity, long-term patency, and a minimally invasive approach that can be performed under local anaesthesia or conscious sedation.…”